Nutritional Therapies in Congenital Disorders of Glycosylation (CDG)
Congenital disorders of glycosylation (CDG) are a group of more than 130 inborn errors of metabolism affecting N-linked, O-linked protein and lipid-linked glycosylation. The phenotype in CDG patients includes frequent liver involvement, especially the disorders belonging to the N-linked protein glyc...
Main Authors: | Peter Witters, David Cassiman, Eva Morava |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-11-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/9/11/1222 |
Similar Items
-
D-galactose supplementation in individuals with PMM2-CDG: results of a multicenter, open label, prospective pilot clinical trial
by: Peter Witters, et al.
Published: (2021-03-01) -
Unsuccessful intravenous D-mannose treatment in PMM2-CDG
by: Sarah C. Grünert, et al.
Published: (2019-10-01) -
CDG Therapies: From Bench to Bedside
by: Sandra Brasil, et al.
Published: (2018-04-01) -
Mannose supplementation in PMM2-CDG
by: Roman Taday, et al.
Published: (2021-08-01) -
New Insights into Immunological Involvement in Congenital Disorders of Glycosylation (CDG) from a People-Centric Approach
by: Rita Francisco, et al.
Published: (2020-07-01)